Nature’s Toolbox
Latest round
- Series B
Last raised
- Nov 2023
Total raised
- $57M
Investors
- 3
About Nature’s Toolbox
Based in the US, Natures Toolbox, Inc. innovates in biomanufacturing, focusing on advanced solutions for the production of mRNA vaccines and protein therapeutics.Natures Toolbox, Inc. specializes in advanced biomanufacturing solutions, providing innovative systems for mRNA and protein production. Founded in 2015 in Rio Rancho, New Mexico, the company has successfully navigated five investment rounds.394 mn. Its founders, Alexander Koglin and Sharief Taraman, have experience in the biotechnology sector, contributing to the company's strategic growth.Nature's Toolbox, Inc. (NTx) specializes in advanced biomanufacturing solutions, specifically through its core products, NTxpress® and NTxscribe®. These systems are designed for the efficient and environmentally sustainable production of mRNA vaccines and protein therapeutics, addressing the demand for rapid, scalable manufacturing in response to public health needs. The NTxpress® platform focuses on mRNA production, while NTxscribe® emphasizes protein synthesis, enabling biopharma companies to innovate and execute clinical trials with increased speed and flexibility. Customers include biopharmaceutical companies, research institutions, and healthcare organizations seeking to enhance their production capabilities and respond effectively to global health challenges.Nature's Toolbox generates revenue primarily through partnerships and direct sales of its proprietary biomanufacturing systems, including NTxpress® and NTxscribe®. Transactions typically involve client engagements for the purchase of these systems alongside ongoing service agreements, which may include maintenance, training, and support. The pricing structure is reflective of the advanced technology and capabilities offered, though specific pricing details are proprietary. NTx's client base encompasses both established pharmaceutical companies and emerging biotech firms, facilitating a diverse array of partnerships aimed at accelerating drug development and manufacturing efficiency.In December 2024, Nature's Toolbox, Inc. The company plans to expand its reach into new markets in Europe and Asia by 2025, while continuing to enhance its product lines with upcoming launches aimed at improving production efficiency.
Who invested in Nature’s Toolbox
3 investors across 2 rounds
See all investors in Nature’s Toolbox
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nature’s Toolbox
Who invested in Nature’s Toolbox?
Nature’s Toolbox has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nature’s Toolbox raised?
Nature’s Toolbox has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nature’s Toolbox last raise money?
Nature’s Toolbox's most recent round on record is a Series B, in Nov 2023.
What does Nature’s Toolbox do?
Based in the US, Natures Toolbox, Inc.
Where is Nature’s Toolbox headquartered?
Nature’s Toolbox is headquartered in Rio Rancho, US.
Which VCs invest in companies like Nature’s Toolbox?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nature’s Toolbox's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nature’s Toolbox? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.